REMPARK, a Personal Health Device for the Remote and Autonomous Management of Parkinson's Disease developed by researchers at Polytechnic University of Catalonia is under testing.
The device measures the person's motor status, evaluates the patient in a clinical setting or records the data for later analysis while the person is involved in daily tasks. It is worn around the torso in a small pouch.
Guidelines to the Diagnosis and Management of Wilson's Disease
Wilson's disease must be considered in anyone whose presenting symptoms include a combination of unexplained liver disease and neurological or neuropsychiatric disorders.
Advertisement
The project aims at achieving accurate results on each person's level of impairment throughout the day and relies less on self-reporting of symptoms. The primary symptoms of Parkinson's disease are, trembling of limbs, jaw, face; stiffness of the limbs, impaired balance and co-ordination.
The symptoms vary from one person to another and the monitoring system can help to decide on the medication regimens that are more appropriate to each person's needs.
![Make Treatment of Parkinsons More Affordable, Doctors Plead]( "Make Treatment of Parkinsons More Affordable, Doctors Plead")
The Parkinson's disease occurs when certain nerve cells in the brain, called the substantia nigra, die or become impaired.
The application of REMPARK will improve management, treatment of the disease and the rehabilitation of patients. Patients will tend to be more independent and comply to medication as it will avoid hospital admissions.
Higher quality and more personalised care for Parkinson's disease patients is possible if REMPARK is incorporated as a tool for diagnosis and monitoring of the disease in Europe. It will improve the healthcare system and increase the sustainability of the public resources used.
Source: Medindia
Make Treatment of Parkinsons More Affordable, Doctors Plead
The Parkinson's disease occurs when certain nerve cells in the brain, called the substantia nigra, die or become impaired.
Advertisement
The application of REMPARK will improve management, treatment of the disease and the rehabilitation of patients. Patients will tend to be more independent and comply to medication as it will avoid hospital admissions.
Higher quality and more personalised care for Parkinson's disease patients is possible if REMPARK is incorporated as a tool for diagnosis and monitoring of the disease in Europe. It will improve the healthcare system and increase the sustainability of the public resources used.
Source: Medindia
Existance of Neurological Diseases Spotted by Brainwave Markers
COGNISION system can be used to detect brainwave markers that point to the existence of certain neurological diseases.
Advertisement
 Diseases Related to Old AgeAgeing is referred to the accumulation of changes that brings a person closer to death. | Advertisement
|
Advertisement
Recommended Reading
Latest Research News
Injury to the white matter explains why football players are at an increased risk for cognitive and behavioral problems later in life.
Located at the South Col, the rocky area between Mount Everest and Lhotse serves as the final campsite for climbers as well as a frozen legacy of hardy microbes.
The new finding is found to be valuable for screening specific medications and treatment against Giardia and other protozoan parasites.
New CRISPR genome-editing strategy was found to have a positive impact in the treatment of inherited retinal diseases such as retinitis pigmentosa.
H3N2 Influenza: The newly developed RT-qPCR Kit to identify influenza, COVID-19 and respiratory virus has got approval from ICMR.